Alnylam

Articles

Two people stand in front of football goal posts holding a football, with a blue football play diagram in the background. November 13, 2026 The Strength Behind the Team: Five Lessons from ATTR-CM Caregiver Kari Shaw Kari Shaw shares five lessons from supporting a loved one with ATTR-CM, including advocacy, teamwork, self-care and the importance of asking questions. Read More ›
a panel of women engage in discussion on stage in front of a large audience October 28, 2026 Expanding Opportunities for Women to Lead Cardiovascular Science Alnylam is working with Women As One, an organization dedicated to advancing opportunities for women in cardiology. Together, we support mentorship, research Read More ›
Ester and her dog kneel on the side of a country path with green fields stretching into the distance October 24, 2026 Celebrating Caregivers – "The People Who Keep Showing Up for You" Read Ester's story and insights on caregiving while living with hereditary ATTR amyloidosis, including lessons on resilience, support, and self-care. Read More ›
A female scientist wearing safety glasses and a lab coat in a lab talking with a colleague October 22, 2026 Alnylam Recognized as a Top Employer by Science Magazine for 8th Year in a Row Being recognized as a Science Top Employer for eight consecutive years reflects the strength of Alnylam's scientific culture and our continued commitment to innovation, collaboration and excellence. Read More ›
Former professional football player Pete Shaw holding a football on a football field October 15, 2026 The Signs Were There: How Pete Shaw and His Team Faced an Unexpected Opponent For former professional football player Pete Shaw, recognizing the signs of hATTR-CM meant looking beyond the expected. Read his story and path to answers. Read More ›
Alnylam and Inceptive AI Collaboration September 2, 2026 Accelerating the Future of RNAi Drug Discovery with AI Alnylam and Inceptive are combining RNAi expertise and advanced AI models to accelerate the design of next-generation RNAi therapeutics. Read More ›
Puzzle pieces featuring protein structures, a digital heart illustration, healthcare analytics, and a clinician, representing collaboration in ATTR research, diagnosis, and patient care August 26, 2026 Advancing Earlier Diagnosis and Coordinated Care in ATTR-CM For patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the path to effective care often begins with a challenge: receiving the right diagnosis before the disease irreversibly advances. Read More ›
Pgarg July 20, 2026 Five Keys to Scaling an Innovation Culture As Alnylam’s clinical pipeline rapidly expands, I’ve found myself reflecting on what has enabled our progress and what it will take to achieve our ambitious 2030 goals. Read More ›
Alnylam Manufacturing 0106 July 8, 2026 Scaling Responsibly: Alnylam’s Approach to Sustainable Operations Growth expands our ability to serve patients. It also expands our responsibility for how that work is done. Modern medicines require energy, water, materials, transportation Read More ›
Alnylam Corporate Responsiblity Report 2025 May 19, 2026 Scaling with Purpose: Alnylam Publishes 2025 Corporate Responsibility Report Alnylam's 2025 Corporate Responsibility Report details our progress against our corporate responsibility goals in stories and data. Read More ›